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Malaria is one of the most important infectious 
diseases worldwide, causing an estimated 500 
million clinical cases and 1–3 million deaths an-
nually (Greenwood et al., 2005). Sporozoites, 
the infective stage of the malaria parasite, de-
velop in mosquitoes and are inoculated into the 
mammalian host, where they ultimately must go 
to the liver, invade hepatocytes, and develop 
into exoerythrocytic stages (exoerythrocytic 
forms [EEFs]). Although sporozoites and the 
EEFs into which they develop are not associated 
with clinical symptoms, this is a time when 
parasite numbers in the host are low and their 
eradication can completely abrogate infection. 
Indeed, sterile protection has been achieved in 
experimental settings using high doses of irradi-
ated sporozoites, making the preerythrocytic 
stages of Plasmodium a focus of the malaria vac-
cine effort (Hoffman et al., 2002). Subunit vac-
cines based on circumsporozoite protein (CSP), 
such as RTS,S, are at the center of this endeavor. 
To date, the development of a malaria vaccine 
has been empirically driven and has yielded 
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Plasmodium sporozoites make a remarkable journey from the mosquito midgut to the 
mammalian liver. The sporozoite’s major surface protein, circumsporozoite protein (CSP), is 
a multifunctional protein required for sporozoite development and likely mediates several 
steps of this journey. In this study, we show that CSP has two conformational states, an 
adhesive conformation in which the C-terminal cell-adhesive domain is exposed and a 
nonadhesive conformation in which the N terminus masks this domain. We demonstrate 
that the cell-adhesive domain functions in sporozoite development and hepatocyte inva-
sion. Between these two events, the sporozoite must travel from the mosquito midgut to 
the mammalian liver, and N-terminal masking of the cell-adhesive domain maintains the 
sporozoite in a migratory state. In the mammalian host, proteolytic cleavage of CSP regu-
lates the switch to an adhesive conformation, and the highly conserved region I plays a 
critical role in this process. If the CSP domain architecture is altered such that the cell-
adhesive domain is constitutively exposed, the majority of sporozoites do not reach their 
target organs, and in the mammalian host, they initiate a blood stage infection directly 
from the inoculation site. These data provide structure–function information relevant to 
malaria vaccine development.
© 2011 Coppi et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Sinnis and Nardin, 2002). The structure of CSP is highly 
conserved among Plasmodium species infecting rodents, pri-
mates, and humans (Fig. 1 A). CSPs are comprised of a cen-
tral repeat region that is diverse across Plasmodium species, 
and flanking the repeats are two conserved domains: region I, 
a 5-aa sequence at the N terminus of the repeats, and a known 
cell-adhesive motif C-terminal to the repeats termed the type I 
thrombospondin repeat (TSR). Studies with recombinant 
CSP, peptides representing portions of CSP, and sporozoites 
expressing heterologous CSP suggest that this protein targets 
sporozoites to both mosquito salivary glands and the mammalian 
liver (Aley et al., 1986; Cerami et al., 1992; Frevert et al., 1993; 
Sinnis et al., 1994; Chatterjee et al., 1995; Sidjanski et al., 1997; 
Pinzon-Ortiz et al., 2001; Suarez et al., 2001; Pradel et al., 2002; 
Rathore et al., 2002; Tewari et al., 2002, 2005). However, 
the region of CSP responsible for this targeting is debated: 
whereas some studies found that sequences within the TSR 
bound with high affinity to hepatocytes (Cerami et al., 1992; 
Frevert et al., 1993; Sinnis et al., 1994; Chatterjee et al., 1995), 
others found no hepatocyte-binding activity within the TSR 
and, in contrast, demonstrated that sequences within the 
N terminus of CSP bound specifically to hepatocytes (Aley 
et al., 1986; Suarez et al., 2001; Rathore et al., 2002). It is 
possible that these conflicting data are the result of peptides 
and recombinant proteins that do not accurately reproduce 
the correct folding of native CSP on the 
sporozoite surface.
Our laboratory has recently shown that 
proteolytic processing of CSP by a parasite 
cysteine protease occurs during invasion of 
hepatocytes (Coppi et al., 2005). Processing 
occurs on the sporozoite surface, and we iden-
tified the sulfation level of liver heparan sulfate 
proteoglycans (HSPGs) as the trigger of this 
event (Coppi et al., 2007). In this study, using 
antisera recognizing different regions of CSP 
and a series of CSP mutants, we define the 
cleavage site and elucidate the function of 
promising though modest results (Ballou, 2009). Thus, an under-
standing of the molecular interactions between sporozoites 
and their mosquito and mammalian hosts is urgently needed to 
design rational interventions for this devastating disease.
The sporozoite’s journey begins on the midgut of the 
mosquito host and ends within hepatocytes of the mamma-
lian host. Sporozoites develop in oocysts on the midgut wall 
and are released into the hemocoel, where they are carried by 
the hemolymph throughout the mosquito’s body cavity, ulti-
mately attaching to and entering salivary glands. As infected 
mosquitoes probe for blood, sporozoites are injected into the 
skin of the mammalian host and actively move by gliding 
motility within the dermis to contact and penetrate blood 
vessels to enter the blood circulation (Amino et al., 2006). 
Exit from the dermal inoculation site requires that sporozo-
ites traverse cell barriers via breaching the plasma membrane 
of the host cell (Mota et al., 2001; Amino et al., 2008), which 
is a qualitatively different process from cell invasion. Once in 
the circulation, sporozoites arrest in the liver, cross the sinu-
soidal barrier, and productively invade hepatocytes within a 
vacuole. Here they develop into EEFs, which, when mature, 
release merozoites that initiate blood stage infection.
The CSP forms a dense coat on the parasite surface and 
has been hypothesized to mediate many of the initial inter-
actions between the sporozoite and its two hosts (Ménard, 2000; 
Figure 1. CSP mutant parasites. (A) Schematic 
diagram of CSP expressed in control and mutant 
parasites. The conserved region I and TSR are shown 
in blue, the species-specific repeats in yellow, and 
signal and anchor sequences in gray. Red lines show 
the length and location of the peptides used to make 
polyclonal antisera to the N- and C-terminal portions 
of CSP (-N and -C sera, respectively). (B) Western 
blot analysis of mutant salivary gland sporozoite 
lysates. The blot was cut in half, and the top was 
probed with polyclonal antiserum specific for TRAP as 
a loading control, and the bottom was probed with 
mAb 3D11 specific for the CSP repeat region. Molecu-
lar mass is indicated in kilodaltons. (C) Phase-con-
trast and fluorescence images of unpermeabilized 
mutant salivary gland sporozoites stained with mAb 
3D11. Bar, 10 µm. Western blots and IFAs were re-
peated twice with similar results.
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were separately introduced into the Plasmodium berghei ANKA 
genome through double homologous recombination, thus re-
placing the WT locus (Fig. S1). Recombinant parasites were se-
lected with pyrimethamine and cloned by limiting dilution 
in mice, and correct integration of constructs was verified by 
PCR, Southern blotting (Fig. S1), and DNA sequencing (not 
depicted). Control parasites (RCon) were identical to WT P. 
berghei ANKA parasites in all aspects (unpublished data) and were 
used throughout this study for comparison with mutant lines.
Mutant RI sporozoites expressed normal amounts of 
CSPRI as evaluated by Western blotting (Fig. 1 B). Further-
more, indirect immunofluorescence assays (IFAs) demon-
strated that it was exported in normal amounts to the 
sporozoite surface (Fig. 1 C). To determine whether CSPRI 
was processed, we performed pulse-chase metabolic labeling 
experiments with sporozoites. Similar to WT CSP, the half-life 
CSP processing. Our study demonstrates that CSP has a two-
domain structure, with each domain having distinct functions as 
sporozoites migrate from mosquito to mammalian host. These 
functional experiments should inform the design of future CSP-
based vaccines.
RESULTS
Region I contains the CSP cleavage site
Previous antibody mapping experiments as well as cleavage 
assays with sporozoites expressing a hybrid CSP indicated that 
proteolytic processing of CSP may occur within the highly con-
served region I (Coppi et al., 2005). To test this hypothesis, we 
generated mutant sporozoites expressing CSP in which region I 
was deleted for comparison with a control parasite line express-
ing WT CSP (RI and RCon sporozoites, respectively; Fig. 1 
A and Fig. S1). The DNA constructs, CSPRI and CSPRCon, 
Figure 2. Phenotype of RI parasites. (A) CSP processing in the absence and presence of hepatocytes. RCon and RI salivary gland sporozoites were 
metabolically labeled with [35S]Cys/Met and kept on ice (time = 0) or chased for the indicated times after which they were lysed, and CSP was immunoprecipi-
tated and analyzed by SDS-PAGE and autoradiography. For experiments with hepatocytes, labeled sporozoites were chased for 1 h in the absence of cells to 
give time for labeled CSP to be exported to the parasite surface (first lane for RCon and not depicted for RI) and then added to Hepa1-6 cells for the indi-
cated times, after which samples were processed as outlined above. Thin gray lines between lanes indicate that lanes were not contiguous on the scanned 
image of the autoradiograph. This experiment was performed three times, and a representative experiment is shown. Molecular mass is indicated in kilodal-
tons. (B) Sporozoite numbers in the mosquito host. Mosquitoes infected with RCon or RI were dissected on the indicated days after blood meal, and the 
number of sporozoites associated with mosquito midguts, hemolymph, or salivary glands was determined. 20 mosquitoes were dissected per time point, and 
shown is the mean number per mosquito. This was repeated with three independent batches of infected mosquitoes, and a representative experiment is 
shown. (C) Infectivity in vitro. RCon or RI sporozoites were added to Hepa1-6 cells and either fixed for an invasion assay (left) or grown for an additional 2 d 
before fixing and staining for EEFs (right). For invasion assays, parallel wells were seeded with sporozoites preincubated with E-64d (hatched bars) to deter-
mine the percentage of intracellular sporozoites that were in the process of cell traversal. 50 fields per well were counted, and shown are the means ± SD of 
triplicate wells. Each experiment was repeated three times with similar results. (D) Infectivity in vivo. C57BL/6 and Swiss Webster mice were injected i.v. with 
104 RCon or RI sporozoites, and 40 h later, mice were sacrificed, total liver RNA was extracted, and liver parasite burden was determined by RT-qPCR. There 
are five mice per group, and shown are the means ± SD. Each experiment was performed three times with similar results.
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parasites to determine the fraction that have productively 
invaded. As shown in Fig. 2 C, RI sporozoites have an 
approximately fivefold reduction in their productive–invasive 
capacity in vitro. We also performed development assays and 
found that the defect in RI EEF development paralleled the 
defect in invasion (Fig. 2 C). However, the EEFs that did 
form were of normal size and morphology (Fig. S3), suggest-
ing that CSP cleavage is required specifically for productive 
invasion and not for downstream processes.
We then tested the infectivity of RI sporozoites in vivo 
using C57BL/6 and Swiss Webster mice. When equal num-
bers of sporozoites were injected into mice i.v. and parasite 
liver load was determined 40 h later by RT–quantitative 
PCR (qPCR), infectivity of RI sporozoites was decreased 
15-fold in C57BL/6 mice and 10-fold in Swiss Webster mice 
compared with controls (Fig. 2 D).
Because mosquitoes inject sporozoites into the dermis 
(Sidjanski and Vanderberg, 1997), we also analyzed the infec-
tivity of RI sporozoites after intradermal (i.d.) inoculation. 
We monitored for the appearance of blood stage parasites 
(prepatent period). A 1-d delay in patency indicates a 90% 
decrease in the infective inoculum (Gantt et al., 1998). As shown 
in Table I, the route of inoculation did not significantly alter 
RI sporozoite infectivity, suggesting that processing of CSP 
is not required for sporozoite exit from the dermis.
Because cell traversal activity and gliding motility are re-
quired for dermal exit (Amino et al., 2006, 2008; Coppi 
et al., 2007), the similar infectivity of RI sporozoites after 
i.v. and i.d. inoculation suggests that they do not have deficits 
in motility or cell traversal. When tested in motility and 
migration assays in vitro, we found that this was the indeed 
the case (Fig. S4). In fact, RI sporozoites had enhanced cell 
traversal activity, a result which is consistent with the previ-
ous demonstration that inhibitors of invasion enhance cell 
traversal, suggesting that if sporozoites do not invade, they 
continue to migrate (Coppi et al., 2007).
Overall, these data suggest that the cleavage site lies within 
the highly conserved 5-aa sequence called region I and dem-
onstrate that region I is required for rapid and complete pro-
cessing of CSP. The small amount of cleavage observed in 
RI sporozoites may result from inefficient cleaving of an 
alternate site; however, limitations in the amount of material 
we can obtain for analysis preclude our being able to verify 
this hypothesis. Importantly, the phenotype of RI sporozo-
ites definitively establishes the link between CSP cleavage 
and hepatocyte invasion and demonstrates that efficient cleav-
age requires region I.
CSP changes conformation twice as sporozoites travel  
from mosquito midgut to mammalian liver
The precise function of proteolytic cleavage of CSP in the 
invasion process was not addressed by the RI mutant; there-
fore, we embarked on additional experiments to elucidate its 
role in this process. Because previous work indicated that the 
entire N-terminal third of CSP is removed after cleavage 
(Coppi et al., 2005), we investigated whether conformational 
of full-length CSPRCon was 1–2 h (Fig. 2 A, top; Coppi et al., 
2005). In contrast, proteolytic processing of CSPRI was 
not detectable.
CSP processing occurs after the protein has been exported 
to the sporozoite surface and is a significantly more rapid pro-
cess in the presence of hepatocytes, suggesting that contact 
with target cells triggers secretion or activation of the respon-
sible protease (Coppi et al., 2005, 2007). To test the effect of 
cell contact on the kinetics of CSPRI cleavage, metabolically 
labeled RCon and RI sporozoites were chased for 1 h in the 
absence of cells, so that labeled CSP had time to be exported 
to the sporozoite surface, and then incubated with hepato-
cytes for different time periods. Cleavage of CSPRCon went to 
completion within 5 min of hepatocyte contact, whereas only 
30% of labeled CSPRI was processed after 30 min (Fig. 2 A, 
bottom). These data demonstrate that CSP processing is sig-
nificantly impaired in the absence of region I.
CSP cleavage is not required in the mosquito host
To determine whether CSP cleavage has a biologically im-
portant function in the mosquito host, RCon or RI sporo-
zoites were counted in oocysts, hemolymph, and salivary 
glands at different time points after blood meal. Deletion of 
region I had no effect on oocyst number, sporozoite devel-
opment in oocysts, or sporozoite egress from oocysts (Fig. 2 B, 
Fig. S2, and Table S1). However, RI parasites consistently 
invaded salivary glands with a 10–15% lower efficiency com-
pared with controls (Fig. 2 B and Table S1). To verify that 
RI salivary gland sporozoites had entered the salivary glands, 
we counted the number of salivary gland sporozoites after 
trypsinization, which removes sporozoites that have not in-
vaded the glands, and found no difference in the ratio of ex-
ternal to internal sporozoites in RI-infected mosquitoes 
compared with controls (Table S2). Overall, these data indi-
cate that CSP processing does not play a significant role in 
the mosquito host.
CSP cleavage functions specifically during  
hepatocyte invasion
We next investigated whether CSP processing plays a role in 
the mammalian host. First, we compared the ability of RCon 
and RI sporozoites to invade and develop in Hepa1-6 cells, 
a hepatoma cell line which is permissive for infection by ro-
dent malaria parasites. Although there was no difference in 
their ability to attach to cells (not depicted), RI sporozoites 
were significantly impaired in their ability to invade (Fig. 2 C). 
Because reliable markers for the early parasitophorous vacu-
ole (PV) are lacking, it is difficult to distinguish intracellular 
sporozoites that have productively invaded from those that 
are in the process of migrating through. To address this, we 
performed invasion assays in the presence of E-64, which in-
hibits CSP processing and is known to greatly hinder inva-
sion but not cell traversal (Coppi et al., 2005, 2007) and 
therefore allows us to estimate the proportion of intracellular 
sporozoites that are in the process of cell traversal. This can 
then be subtracted from the total proportion of intracellular 
JEM VOL. 208, February 14, 2011 
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TSR (Fig. 3, B and C). The direct role of CSP cleavage in this 
event is demonstrated by the finding that RI sporozoites 
retained reactivity to the N-terminal antiserum (Fig. 3 B and 
Fig. S6) and did not gain reactivity to C-terminal antiserum 
even after incubation with hepatocytes (Fig. 3 B). However, 
after prolonged contact with cells, a small proportion of RI 
sporozoites were recognized by the C-terminal antiserum, 
which is consistent with our previous findings that CSPRI is 
cleaved slowly and inefficiently (Figs. 2 A and 3, B and C).
Together, these data indicate that the cell-adhesive TSR 
of CSP is exposed twice during the sporozoite’s life: during 
their development in the oocyst and after reaching their final 
destination, the hepatocyte. The phenotype of the RI 
mutant indicates that proteolytic processing of CSP is re-
quired for TSR exposure in the mammalian host, i.e., during 
hepatocyte invasion, but not for its exposure during sporozoite 
development in the mosquito host.
Mutants expressing cleaved CSP develop more sporozoites 
that are unable to target salivary glands
To further investigate the function of proteolytic processing 
of CSP, we generated a mutant parasite line in which the 
N-terminal third of the protein was deleted so that mutant 
sporozoites expressed only cleaved CSP on their surface 
changes in CSP were associated with cleavage. To test this, 
we performed IFAs on RCon sporozoites using polyclonal 
antisera directed against the N or C terminus of CSP. These 
antisera were generated using the long peptides shown in 
Fig. 1 A, and their fine specificity is presented in Fig. S5 and 
a previous publication (Coppi et al., 2005).
We tested the reactivity of surface CSP on different spo-
rozoite populations, i.e., oocyst, hemolymph, and salivary 
gland. Interestingly, antisera specific for the C terminus 
bound to oocyst sporozoites but did not recognize hemo-
lymph or salivary gland sporozoites, whereas antisera specific 
for the N terminus of CSP recognized hemolymph and sali-
vary gland sporozoites but not oocyst sporozoites (RCon in 
Fig. 3 A). In these experiments, sporozoites were fixed with 
paraformaldehyde (PFA) and not permeabilized so that the 
conformation of surface CSP could be ascertained. These ex-
periments were corroborated by experiments on live sporo-
zoites stained at 4°C (unpublished data). We then tested the 
reactivity of salivary gland sporozoites after their addition to 
hepatocytes because CSP cleavage occurs upon contact with 
hepatocytes (Coppi et al., 2007). In the presence of hepatocytes, 
the majority of RCon sporozoites lost their reactivity to the 
N-terminal antiserum and gained reactivity to the C-terminal 
antiserum, suggesting that cleavage functions to unmask the 
Table I. Infectivity of CSP mutant sporozoites as determined by prepatent period
Experiment and mouse 
strain
Parasite line Route of inoculation Number of sporozoites 
injected
Number of mice 
positive/number of 
mice injected
Prepatent period
d
Experiment 1
Swiss Webster RCon i.v. 5,000 5/5 3.0
RCon i.d. 5,000 5/5 3.0
RI i.v. 5,000 5/5 5.0
RI i.d. 5,000 5/5 5.0
Experiment 2
C57BL/6 RCon i.d. 1,000 5/5 4.2
RCon i.d. 10,000 5/5 3.0
Nfull i.d. 1,000 0/5 NA
Nfull i.d. 10,000 5/5 13.8
Nfull i.d. 100,000 5/5 11.4
Experiment 3
Swiss Webster RCon i.d. 1,000 5/5 4.6
RCon i.d. 10,000 5/5 3.0
Nfull i.d. 1,000 0/5 NA
Nfull i.d. 10,000 5/5 14.4
Nfull i.d. 100,000 5/5 12.0
Experiment 4
Swiss Webster RCon i.v. 100 2/3 5.5
RCon i.v. 1,000 3/3 3.7
Nfull i.v. 100 3/3 3.0
Nfull i.v. 1,000 3/3 3.0
NA, not applicable.
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We first investigated the phenotype of the Nfull mutant 
in the mosquito, enumerating oocyst, hemolymph, and sali-
vary gland sporozoites at the indicated time points after an 
infective blood meal. Interestingly, the Nfull mutant pro-
duced between 50 and 100% more sporozoites in oocysts 
compared with control lines (Fig. 4 A and Table S1). How-
ever, despite the high number of developing sporozoites, this 
(Nfull sporozoites; Fig. 1 A and Fig. S1). This mutant was 
generated by replacement of the endogenous CSP locus with 
the CSPNfull allele and verified as previously outlined (Fig. S1). 
Protein expression and surface localization of CSPNfull were 
similar to WT CSP (Fig. 1, B and C). However, in contrast 
to WT sporozoites, this mutant expresses CSP in which the 
TSR is constitutively exposed (Fig. 3 A).
Figure 3. Exposure of the C-terminal TSR is a controlled process. (A) Phase-contrast and fluorescence images of oocyst, hemolymph, and salivary 
gland sporozoites from RCon- and Nfull-infected mosquitoes stained with antiserum specific for the CSP N (-N; top) or C terminus (-C; bottom). The 
percentage of 200 sporozoites staining with each respective antiserum is shown. (B) Exposure of the C terminus on RCon and RI sporozoites after con-
tact with hepatocytes. Shown are fluorescence images of RCon and RI salivary gland sporozoites 5 min after addition to Hepa1-6 cells stained with 
mAb 3D11, which stains all sporozoites (green), and -N or -C sera (red). (C) Graph showing the percentage of WT, RCon, or RI salivary gland sporozo-
ites staining with -N or -C sera at the indicated time points after their addition to Hepa1-6 cells. Total sporozoite number was determined by staining 
with mAb 3D11. Shown are the means of triplicate wells ± SD; 100 sporozoites per well were counted. All IFAs were repeated two to three times, and a 
representative experiment is shown. Bars, 10 µm.
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Figure 4. Phenotype of Nfull sporozoites in the mosquito. (A) Oocyst and salivary gland sporozoite numbers. Mosquitoes infected with RCon or 
Nfull parasites were dissected on the indicated days after blood meal, and the number of sporozoites (spz) associated with midguts or salivary glands 
was determined. 20 mosquitoes were dissected per time point, and shown is the mean number per mosquito. This was repeated with three independent 
batches of infected mosquitoes and a representative experiment is shown. (B) Distribution of Nfull sporozoites in the mosquito. Mosquitoes infected 
with RCon or Nfull parasites were dissected on the indicated days after blood meal, and midguts, salivary glands, thoraces without salivary glands, and 
abdomens without midguts were obtained, and the total number of sporozoites associated with each organ was determined by RT-qPCR. Organs from  
20 mosquitoes were obtained per time point, and shown is the mean number of RCon and Nfull sporozoites associated with the mosquito midgut over 
time (top), the mean number of RCon sporozoites associated with salivary glands, the thorax, or abdomen over time (middle), and the mean number of 
Nfull sporozoites associated with salivary glands, thorax, or abdomen over time (bottom). The experiment was performed twice with similar results.   
(C) Transmission electron micrographs of oocysts from mosquitoes infected with RCon or Nfull parasites at day 12 after blood meal. Between 8 and  
12 oocysts were observed per parasite line, and an average of two sections per oocyst was performed. Shown are representative images.
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mutant consistently had 10-fold fewer salivary gland sporo-
zoites compared with controls (Fig. 4 A and Table S1).
Increased numbers of sporozoites could have one of 
two causes: either the mutant produces more oocysts, or 
within each oocyst more sporozoites develop. Comparison 
of oocyst numbers in RCon- and Nfull-infected mosqui-
toes revealed no differences (Fig. S2), suggesting that within 
each Nfull oocyst, more sporozoites developed. Sporozo-
ites develop in oocysts by schizogony, a replication process 
in which nuclear division precedes the formation of daugh-
ter cells (Sinden and Strong, 1978). The early oocyst con-
tains one or more cytoplasmic islands called sporoblasts, 
and sporozoites bud from sporoblasts at sites where an 
inner membrane complex has been deposited along the plas-
malemma. As the sporozoite buds, cytoplasmic components 
such as the nucleus, mitochondria, and other organelles are 
pulled into the forming sporozoite. Ultimately, the oocyst 
is full of sporozoites, and the sporoblast resembles a residual 
body. To examine this process in the Nfull mutant, we 
performed electron microscopy on oocysts from infected 
mosquito midguts. At early time points after infective 
blood meal, we saw no differences in the morphology be-
tween RCon and Nfull oocysts (Fig. S7 A). However, 
once sporozoite budding began, sporoblasts from Nfull 
mutant oocysts exhibited increased budding (Fig. 4 C and 
Fig. S7, A and B). These sporozoites showed normal mor-
phology, having a canonical crescent shape and size with 
one nucleus per sporozoite (Fig. S7, B and C). Thus, the 
conformation of CSP in the Nfull mutant leads to en-
hanced budding and increased numbers of sporozoites de-
veloping in the oocyst.
Despite these increased numbers, there was a 10-fold 
reduction in the number of Nfull sporozoites that reached 
the salivary glands (Fig. 4 A and Table S1). To better under-
stand this, we followed the distribution of Nfull and RCon 
sporozoites in the mosquito over time by RT-qPCR. Both 
RCon and Nfull sporozoites exited oocysts between days 
14 and 20 after blood meal (Fig. 4 B, top). After their release 
from oocysts, RCon sporozoite numbers increased in salivary 
glands, and only small numbers of these sporozoites were 
found associated with other tissues (Fig. 4 B, middle). In con-
trast, after their release from oocysts, Nfull sporozoites were 
found throughout the mosquito and only in low numbers 
in salivary glands (Fig. 4 B, bottom). However, the Nfull 
sporozoites that did make it to the salivary glands were 
able to invade the glands in proportions similar to controls 
(Table S2). Overall, these data suggest that exposure of the 
cell-adhesive TSR on hemolymph Nfull sporozoites leads 
to their nonspecific adhesion throughout the mosquito, thus 
explaining why they do not reach the salivary glands in suffi-
cient numbers.
Mutants expressing cleaved CSP have enhanced infectivity
Nfull sporozoites that successfully reached the salivary 
glands could be used to investigate the role of the N ter-
minus of CSP as well as the function of its removal in the 
mammalian host. In vitro, Nfull salivary gland sporozo-
ites displayed a higher invasion efficiency compared with 
controls (Fig. 5 A). Because we could not use E-64 to distin-
guish between productively invaded versus migratory spo-
rozoites as CSPNfull is expressed as its cleaved form, we 
stained intracellular parasites with antisera to UIS-4, a 
marker for the PV (Tarun et al., 2007). UIS-4 staining indi-
cated that the majority of Nfull mutants had productively 
invaded the cells (Fig. 5 A), and this was confirmed by the 
finding that they also produced more EEFs compared with 
Figure 5. Infectivity of Nfull sporozoites in the mammalian host. 
(A) In vitro infectivity. RCon or Nfull sporozoites were added to Hepa1-6 
(Hepa), MDFs, or HBMVEC (HBM) for 1 h (invasion), 6 h (PV formation), or 
2 d (EEF development), fixed, and stained. Invasion was scored using a 
double staining assay that distinguishes intracellular from extracellular 
sporozoites, and shown is the percentage of total sporozoites that are 
intracellular (left). To determine whether sporozoites entered in a vacuole, 
replicate wells were fixed 6 h after infection and stained with mAb 3D11 
and anti–UIS-4, a marker for the PV, and shown is the percentage of total 
sporozoites that are in a vacuole (left; hatched bars). In the right panel, 
the number of EEFs developing for each parasite line is shown. For each 
experiment, 50 fields per well were counted, and shown are the means ± 
SD of triplicate wells. The difference in invasion efficiency and EEF devel-
opment between RCon and Nfull sporozoites in all cell lines was signifi-
cant with p-values <0.01. Experiments were repeated three times with 
similar results. (B) In vivo infectivity. Mice were injected either i.v. or i.d. 
with 104 RCon or Nfull sporozoites, and 40 h later, total liver RNA was 
extracted, and liver parasite burden was determined by RT-qPCR. There 
were five mice per group, and the liver parasite burden of each mouse is 
shown. The experiment was performed three times with similar results.
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Previous studies have shown that in the mammalian host, 
inoculated sporozoites have two distinct states of being: they 
can be in a migratory mode, traversing cells with which they 
come into contact, or they can be in an invasive mode, which 
leads to cell entry in a vacuole and progression to the next life 
cycle stage (Mota et al., 2002; Coppi et al., 2007; Amino 
et al., 2008). We have previously found that sporozoites that 
are inhibited from invading remain in migration mode (Coppi 
et al., 2007). Thus, we would predict that sporozoites that 
are primed for invasion would migrate less. When we quan-
tified the migratory activity of Nfull sporozoites, we indeed 
found that they were less migratory compared with controls, 
supporting the hypothesis that they have an invasive pheno-
type (Fig. S4).
Mutants expressing cleaved CSP do not exit the dermis  
and initiate infection from this site
Because mosquitoes inoculate sporozoites i.d. (Sidjanski and 
Vanderberg, 1997; Medica and Sinnis, 2005; Amino et al., 
2006), infectivity by this route of entry is critical for continu-
ation of the parasite’s life cycle. Our results indicate that 
by the i.d. route, Nfull sporozoites have a very low capacity 
to initiate malaria 
infection possibly 
because these spo-
rozoites cannot exit 
the dermis. To test 
this, we measured 
sporozoite numbers 
at the injection site 
after i.d. inocula-
tion by qPCR. As 
shown in Fig. 6 A, 
controls (Fig. 5 A). We also tested the infectivity of Nfull 
sporozoites for normally less permissive cell lines such as 
mouse dermal fibroblasts (MDFs) and an endothelial cell 
line (human brain microvascular endothelial cell [HBMVEC]) 
and found that Nfull sporozoites also have enhanced inva-
sive capacity for these cell lines (Fig. 5 A). The enhanced 
infectivity of Nfull sporozoites suggests that these para-
sites are primed for invasion because CSP on their surface 
is already cleaved.
We next determined the infectivity of Nfull sporozo-
ites in vivo. When injected i.v., the results paralleled the in 
vitro data in that these sporozoites had higher infectivity in 
both Swiss Webster and C57BL/6 mice (Fig. 5 B and Table I). 
However, in contrast to the enhanced infectivity observed 
after i.v. inoculation, we could not detect parasite signal in 
the liver after i.d. inoculation of Nfull sporozoites (Fig. 5 B). 
To further investigate the infectivity of Nfull sporozoites 
after i.d. inoculation, we injected sporozoites and then 
monitored for blood stage infection. The rationale for these 
experiments is that the RT-qPCR assay may not detect 
very low numbers of developing parasites in the liver, 
whereas a single infected hepatocyte will give rise to a de-
tectable blood stage infection. As shown in Table I, i.d. 
inoculation of 103 or 104 RCon sporozoites resulted in a 
detectable blood stage infection by days 3–4 after inocula-
tion. In contrast, i.d. inoculation of 103 Nfull sporozoites 
never gave rise to a blood stage infection. However, when 
we inoculated higher numbers, 104 and 105 Nfull sporo-
zoites, we observed blood stage infections with a 10-d delay 
compared with controls (Table I). In the next section, we 
outline experiments performed to investigate the large dif-
ference in infectivity of Nfull sporozoites after i.v. versus 
i.d. inoculation.
Figure 6. Nfull sporozoites do not exit 
the dermis and can seed the blood directly 
from this location. (A) Kinetics with which 
Nfull parasites disappear from the inocula-
tion site. Swiss Webster mice were injected i.d. 
in the ear with 5,000 RCon or Nfull sporo-
zoites, ears were removed at the indicated 
time points, and the number of sporozoites in 
each ear was quantified by qPCR. There are 
four mice per group, and shown are the 
means ± SD. The differences between RCon 
and Nfull sporozoite numbers remaining in 
the skin at 18–90 h were statistically signifi-
cant with p-values <0.001, whereas differ-
ences in sporozoite numbers at earlier times 
points did not reach significance. The experi-
ment was performed twice with similar re-
sults. (B) Expression of sporozoite- and 
EEF-specific genes at the inoculation site. 
Swiss Webster mice were injected with RCon 
(left) or Nfull (right) sporozoites i.d., ears 
were removed at the indicated time points, 
total RNA was extracted, and the expression 
of TLP and MSP-1 was quantified by RT-qPCR. 
There were four mice per group, and shown 
are the means ± SD. (C) Removal of the in-
oculation site between 22 and 40 h after 
sporozoite injection abrogates blood stage 
infection by Nfull sporozoites. 104 Nfull 
sporozoites were inoculated i.d. into one ear, 
and the ear was either left intact or removed 
at the indicated time points. All mice were 
followed for 30 d for the appearance of blood 
stage parasites by Giemsa-stained blood 
smears. Shown are the combined results of 
two independent experiments.
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inoculation site for >40 h before leaving, if this were the case, 
we would expect to see blood stage infection with a 2–4-d 
delay rather than 10-d delay because once in the liver, Nfull 
sporozoites develop normally.
Mutants expressing cleaved CSP gain susceptibility  
to antibodies targeting the TSR
The phenotype of Nfull sporozoites suggests that one func-
tion of masking the TSR is to maintain the sporozoites in a 
migratory state, enabling them to complete their journey to 
the liver. To test whether this has an additional role of pro-
tecting sporozoites from antibodies targeting an important 
functional domain, the TSR, we compared the infectivity of 
RCon and Nfull sporozoites in the presence of polyclonal 
antisera specific for the C terminus. As shown in Fig. 7, 
polyclonal antisera specific for the C terminus had no effect 
on RCon sporozoite infectivity in vitro or in vivo. In con-
trast, Nfull sporozoites were inhibited from invading Hepa1-6 
cells in the presence of this antiserum, and their infectivity 
was significantly diminished in vivo when mice were prein-
jected with the antiserum. These data suggest that unmask-
ing the C terminus at the moment of hepatocyte contact also 
functions to protect sporozoites from antibodies targeting 
the TSR.
DISCUSSION
The data presented in this study provide a molecular basis for 
understanding how sporozoites travel from mosquito midgut 
to mammalian liver, a journey which must be completed to 
establish infection. Although a significant amount of previous 
work has demonstrated that CSP has critical roles in many 
steps of this journey (Ménard, 2000; Sinnis and Nardin, 
2002), there has been no unifying hypothesis as to how one 
protein functions in so many disparate events. In this study, 
we show that CSP has two conformational states, an adhesive 
conformation in which the TSR is exposed and a nonadhe-
sive conformation in which the TSR is masked by the N ter-
minus. Furthermore, we show that each of these conformations 
is associated with distinct functional properties. 
The TSR-exposed conformation occurs at the 
RCon sporozoites disappeared from the injection site with 
kinetics similar to what has been previously published for 
Plasmodium yoelii sporozoites (Yamauchi et al., 2007). In con-
trast, Nfull sporozoite numbers in the injection site de-
creased only marginally over time (Fig. 6 A), demonstrating 
that they do not efficiently exit the dermis. To determine 
whether they are developing in this location, we measured 
sporozoite- and EEF-specific transcripts in the dermal inocu-
lation site over time. As shown in Fig. 6 B, Trap-like protein 
(TLP) transcripts, which are specific to the sporozoite stage 
(Moreira et al., 2008), were robustly detected after RCon or 
Nfull sporozoite inoculation into the dermis (Fig. 6 B). 12 
h later, Nfull sporozoites remained in the skin, and TLP 
transcripts continued to be detected, whereas RCon sporo-
zoites had exited the inoculation site (Figs. 6, A and B). 
Interestingly, at 48 h after Nfull sporozoite inoculation, we 
no longer detected TLP transcripts but observed robust ex-
pression of MSP-1 (merozoite surface protein 1) transcripts, 
which are associated with the development of merozoites in 
late stage EEFs (Fig. 6 B; Sinden et al., 1990).
These findings raised the possibility that blood stage in-
fection after i.d. inoculation of Nfull sporozoites was 
caused by parasites that remained in the skin. To that end, 
we inoculated Nfull sporozoites into the ears of mice, re-
moved the inoculation site at different time points, and 
monitored the mice for blood stage infection. Normal de-
velopment of rodent malaria EEFs takes 46 h. Interest-
ingly, none of the mice whose ears were removed at 22, 38, 
or 40 h after sporozoite inoculation became patent for blood 
stage parasites, whereas mice whose ears were removed at 
later time points developed blood stage infections (Fig. 6 C). 
These data suggest that Nfull parasites are seeding the 
blood directly from the inoculation site. Furthermore, the 
significantly prolonged prepatent periods observed suggest 
that this occurs with low efficiency, possibly because of the 
difficulty that merozoites of mature skin EEFs have in ac-
cessing the blood circulation. Although these data could also 
be explained by a few Nfull sporozoites that lingered at the 
Figure 7. Just-in-time exposure of the TSR pro-
tects sporozoites from antibody-mediated inhibition. 
The effect of -C serum on the infectivity of RCon  
and Nfull sporozoites was tested in vitro (left) and  
in vivo (right). In vitro, sporozoites were added to Hepa1-6 
cells in the presence (+) or absence () of -C serum 
for 1 h, cells were fixed and stained, and the percentage 
of intracellular sporozoites was determined. 50 fields 
per well were counted, and shown are the means ± SD 
of triplicate wells. In vivo, -C serum (+) or buffer alone 
() was injected i.v. into C57BL/6 mice, and 5 min later, 
104 RCon or Nfull sporozoites were inoculated i.v., and 
40 h later, liver parasite burden was determined by RT-
qPCR. There are five mice per group, and shown are the 
means ± SD. Each experiment was performed three 
times with similar results.
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2002; Coppi et al., 2007; Amino et al., 2008). Our data 
expand on this previous work and establish a link between 
the activation state of the sporozoite and the conformation 
of CSP. RI sporozoites, which are significantly impaired 
in their ability to cleave CSP and so retain full-length CSP 
on their surface, are poorly infectious yet have enhanced 
migratory activity. In contrast, Nfull sporozoites, which 
express cleaved CSP on their surface, have enhanced infec-
tivity and are less migratory. Furthermore, these data sup-
port the notion that the TSR is involved in the invasion 
process itself; however, its role in this process remains to be 
determined. Although the environmental signal or signals 
that trigger activation are the subject of debate, it is likely 
that the highly sulfated HSPGs of hepatocytes are involved 
in this process (Coppi et al., 2007). Importantly, the link be-
tween a cell’s adhesiveness and its activation state is found in 
several other biological systems, including the immune system 
(Springer, 1990).
In the mammalian host, dermally inoculated Nfull mu-
tants cannot exit the dermis but develop and initiate blood 
stage infection from the inoculation site. Previous studies 
have shown that a small proportion of WT rodent malaria 
sporozoites remain in the dermis and can develop into what 
appear to be mature EEFs (Gueirard et al., 2010; unpublished 
data). However, given the low numbers of these skin EEFs, 
it has been difficult to demonstrate that they can initiate a 
blood stage infection. In contrast, Nfull sporozoites express 
CSP in the adhesive, TSR-exposed conformation, which 
leads to a larger proportion of the inoculum remaining in the 
skin and confers upon these sporozoites an enhanced infec-
tivity for normally less permissive cell types. Thus, these spo-
rozoites may be a good tool to study skin stage EEFs in vivo. 
The very long prepatent periods observed after i.d. inoculation 
two ends of the sporozoite’s life, during sporozoite develop-
ment and hepatocyte invasion. Moreover, the phenotype of 
our CSP mutants suggests that the TSR functions during 
these two critical processes. Between these two spatially and 
temporally distinct events, the N terminus masks the TSR, a 
conformation which confers a migratory phenotype upon 
sporozoites. This is supported by our finding that sporozoite 
mutants in which the N terminus is deleted adhere throughout 
the mosquito hemocoel and cannot exit the mammalian dermis 
though they are fully infectious when inoculated i.v. In the 
mammalian host, proteolytic cleavage within region I is the 
link between the nonadhesive and adhesive conformation of 
CSP. A model summarizing these data is shown in Fig. 8.
This model changes the currently held view that the TSR 
targets sporozoites to the liver (Ménard, 2000; Sinnis and 
Nardin, 2002), a hypothesis which was based on studies with 
recombinant CSP demonstrating that the TSR binds specifi-
cally to hepatic HSPGs (Cerami et al., 1992; Frevert et al., 
1993; Sinnis et al., 1996) and on the previously accepted 
notion that inoculated sporozoites rapidly target the liver 
(Cerami et al., 1994; Sinnis et al., 1996). Recent studies 
demonstrating that sporozoites are inoculated into the dermis 
(Sidjanski and Vanderberg, 1997) and exit this location in a 
slow trickle that extends for hours (Yamauchi et al., 2007) 
suggest that the old model may be in need of revision. Our 
demonstration that premature exposure of the TSR prevents 
sporozoites from reaching the liver when inoculated into the 
skin (as they are in natural infection) provides further support 
for this revision.
Our new model (Fig. 8) is in agreement with recent work 
demonstrating that sporozoites are in a migratory noninvasive 
state when inoculated into the skin and that they become 
activated for invasion after reaching the liver (Mota et al., 
Figure 8. A model for the role of CSP in the sporozoite’s journey. Model showing the correlation between the conformation of CSP on sporozoites 
and their location/developmental stage in both mosquito and mammalian hosts. Below each heading is a picture of sporozoites in that location, in which 
green sporozoites have the N terminus exposed and red sporozoites have the C terminus exposed. Below each group of sporozoites is a schematic of CSP, 
in which green shows the N terminus, red shows the C terminus, gray shows the repeats, and in yellow is the protease that cleaves CSP.
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is cleaved after hepatocyte contact, suggesting that the pro-
cess of salivary gland invasion is qualitatively different from 
hepatocyte entry.
In the mammalian host, proteolytic cleavage of CSP reg-
ulates the switch to an adhesive conformation, and our data 
suggest that the highly conserved region I contains the cleav-
age site. This hypothesis is supported by our previously pub-
lished antibody mapping experiments as well as pulse-chase 
metabolic labeling experiments with sporozoites expressing a 
hybrid CSP (Coppi et al., 2005), which indicated that neither 
the repeat region nor the upstream portion of the N terminus 
contain the cleavage site. We have tried to determine the 
precise cleavage site within region I by N-terminal sequencing 
of native cleaved CSP; however, this work has never yielded 
robust reproducible results because of the small amount of 
native CSP that we are able to isolate from sporozoites. Thus, 
it remains possible that region I is required for efficient cleav-
age but does not itself contain the cleavage site. We hypothe-
size that the small amount of cleavage observed in region I 
deletion mutants is likely caused by inefficient processing at 
an alternative, upstream site, although we have not been able 
to map the alternate cleavage site because of limitations 
in sporozoite material for these experiments. Overall, the conser-
vation of region I in CSPs from all species of Plasmodium in ad-
dition to the low infectivity of region I deletion mutants suggest 
that cleavage is an essential process for sporozoite infectivity.
In contrast to our findings, a previous study in which 
region I of CSP was deleted found no effect on sporozoite 
infectivity compared with the parental line (Tewari et al., 
2002). However, in that study, the deletion was introduced 
into a P. berghei line in which the endogenous CSP gene was 
replaced by Plasmodium falciparum CSP, Pb(PfCSP). Yet this 
parental line, Pb(PfCSP), invades salivary glands with a 10-fold 
lower efficiency compared with WT sporozoites (Fig. S8 A; 
Tewari et al., 2002), raising the possibility that P. falciparum 
CSP does not fold properly on the surface of P. berghei sporo-
zoites. To test this, we performed IFAs with Pb(PfCSP) spo-
rozoites and polyclonal antisera specific for the TSR of 
P. falciparum CSP and found that in contrast to WT P. falci-
parum sporozoites, the TSR is accessible to antibodies on the 
surface of Pb(PfCSP) sporozoites (Fig. S8 C). The exposure 
of the TSR in the full-length CSP expressed by these para-
sites begins to explain why deletion of region I does not affect 
their infectivity for hepatocytes, as cleavage would no longer 
be necessary for TSR exposure. Furthermore, when we in-
vestigated whether these transgenic sporozoites have a lower 
infectivity for salivary glands as the result of premature expo-
sure of the TSR, we found that this was indeed the case 
(Fig. S8 B). Together, these data suggest that although the 
overall structure of CSP is conserved among all Plasmodium 
species, CSPs may not fold correctly in heterologous species.
Our findings are relevant to malaria vaccine develop-
ment. Sterile immunity to the preerythrocytic stages of Plas-
modium can be generated with high doses of irradiated 
sporozoites (Hoffman et al., 2002), and CSP is an important 
component of this protective response (Kumar et al., 2006). 
of Nfull sporozoites is unusual as one sporozoite success-
fully infecting a hepatocyte can lead to a blood stage infection 
in 7–8 d. We hypothesize that this is because the skin lacks 
easy access to the blood circulation, making it difficult for 
merozoites to access their target, the erythrocyte. Thus, it is 
likely that only a very small number of the merozoites that 
develop in Nfull skin EEFs ultimately reach the blood, which 
in turn would necessitate several rounds of multiplication be-
fore sufficient parasite numbers accumulate such that they are 
detectable by blood smear.
Although our data suggest how the domain structure of 
CSP can confer multiple functions, several questions remain 
as to the precise roles played by both the TSR and the 
N-terminal domain. In the case of the TSR, our findings 
build upon previous studies demonstrating a critical role for 
CSP in sporozoite development (Ménard et al., 1997; Thathy 
et al., 2002). Specifically, our demonstration that the TSR of 
CSP is exposed in oocyst sporozoites and that Nfull oocysts 
exhibit significantly increased sporozoite budding suggests a 
role for this domain in the budding process. The TSR is 
found in >100 proteins, and studies of other TSR-containing 
proteins such as UNC-5 and F-Spondin show that this do-
main is involved in guiding cell migration in the developing 
nervous system (Adams and Tucker, 2000). Thus, it is possi-
ble that the TSR plays a role in guiding budding sporozoites 
into the oocyst vacuolar space, and further studies testing this 
hypothesis are underway. Although we demonstrate that the 
TSR of CSP is exposed on oocyst sporozoites, proteolytic 
cleavage is not required for TSR exposure in this location 
because sporozoite development is not affected in cleavage 
site mutants. Therefore, it is possible that a chaperone protein 
binds to CSP in oocysts to maintain the exposure of the TSR 
and then dissociates as sporozoites exit the oocyst, leading to 
a conformational change in CSP.
Our findings suggest that the N-terminal third of CSP 
forms a functional domain whose role is to mask the cell- 
adhesive TSR. However, the N terminus may also have ad-
hesive properties of its own. This hypothesis is supported by 
previous studies demonstrating that the N terminus of CSP 
binds specifically to mosquito salivary glands (Sidjanski et al., 
1997; Myung et al., 2004). Thus, the N terminus may both 
prevent nonspecific adhesion of sporozoites throughout the 
mosquito hemocoel and in some way aid sporozoites in tar-
geting salivary glands. If this is the case, the interaction be-
tween the CSP N terminus and the salivary gland surface is 
likely to be a low affinity recognition event that is followed 
by high affinity interactions with other sporozoite ligands 
such as MAEBL and TRAP (Kariu et al., 2002; Saenz et al., 
2008; Ghosh et al., 2009). A similar scenario may also occur 
in the mammalian host. Indeed, our demonstration that the 
N terminus and not the TSR is exposed on salivary gland 
sporozoites suggests that the initial interaction between spo-
rozoite and liver involves this domain of CSP, a hypothesis 
which is supported by previous studies demonstrating that 
the N terminus binds to hepatic HSPGs (Rathore et al., 2001, 
2002). However, in contrast to salivary gland invasion, CSP 
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and then digested with the appropriate restriction enzymes and ligated 
overnight at 14°C using T4 DNA ligase. Because several ligation prod-
ucts were possible, we performed a PCR amplification of the correct liga-
tion product with primers spanning the 873-bp PmlI–PacI fragment for 
the RI CSP mutant and primers spanning the KpnI–PacI fragment for 
the Nfull CSP mutant. Mutant CSP genes or gene fragments were then 
cloned into pCR4-TOPO and sequenced to verify that region I or the 
entire N terminus was deleted and that the repeat region was intact. The 
CSP PmlI–PacI fragment with region I deleted or the CSP Kpn-Pac frag-
ment with the N terminus deleted was then cloned into pCSComp (Thathy 
et al., 2002) replacing WT CSP.
Generation of mutant parasites. Recombinant P. berghei ANKA strain 
parasites were generated by double homologous recombination in which 
the native CSP locus was replaced by a WT or mutant copy of CSP with 
its control elements and a selection cassette (Fig. S1 B). The transfection 
plasmid (pCSRep) was built from pCSComp (Thathy, et al., 2002), which 
has a drug selection cassette consisting of a copy of the human DHFR gene 
flanked by 2.2 kb of 5 untranslated region (UTR) and 0.55 kb of 3 UTR 
of P. berghei DHFR-TS, followed by a CSP cassette consisting of a WT 
copy of the P. berghei CSP gene flanked by 1.3 kb of CSP 5 UTR and 450 bp 
of CSP 3 UTR. To generate a targeting construct that would replace 
the endogenous CSP locus, we cloned additional CSP 5 UTR upstream 
of the selection cassette. This was obtained from p9.5E (Thathy et al., 
2002) between the EcoRV and XbaI sites, using forward (5-GTGCTC-
GAGTAATATATGAAAATAATGAATGAGG-3; introduced XhoI site 
underlined) and reverse primer (5-CTCGTCGACAATAAATTGGTT-
TATGAAATTAGC-3; introduced HincII site underlined). The resulting 
730-bp PCR product was cloned into pCR4-TOPO (Invitrogen), and 
terminal restriction sites were then added for cloning into pCSComp 
using forward (5-AAACTGCAGCTCGAGTAATATATGAAAATA-
ATGAATG-3; introduced PstI site immediately before the existing 
XhoI site underlined) and reverse primer (5-AAAACTGCAGACAATA-
AATTGGTTTATGAAATTAGC-3; introduced PstI site underlined). 
The PCR product was cloned, its sequence verified, and then cloned into 
the PstI site at the 5 end of the selection cassette in pCSComp. This final 
construction was called pCSRep and contained WT or mutant CSP. WT 
P. berghei ANKA schizonts collected from Wistar rats were electroporated 
with 5 µg DNA as previously outlined (Janse et al., 2006), injected into 
mice, and selected with pyrimethamine and cloned by limiting dilution 
in mice.
Southern blot and PCR verification of CSP mutants. Integration of 
the transfected DNA at the correct location was verified for each recombi-
nant clone by PCR and Southern blotting (Fig. S1 C), and the CSP sequence 
of the resulting clones was verified by sequencing. PCR to verify integration 
at the CSP locus was performed with primers DP1 (5-AATGAGAC-
TATCCCTAAGGG-3) and DP2 (5-TAATTATATGTTATTTTATT-
TCCAC-3). Southern blotting was performed with genomic DNA from 
erythrocytic stage parasites digested with EcoRV and probed with the 873-
bp PmlI–PacI fragment of CSP, which was labeled with digoxigenin-dUTP 
by random priming and detected using the DIG High Prime DNA Labeling 
and Detection kit (Roche). In addition, the CSP coding sequence of each 
clone was amplified using primers P3 (5-GAGCTATGTTACAAT-
GAAGG-3) and P4 (5-AAATTCTAGTATTTTTTCCGCGC-3) and 
sequenced to confirm that the deletion was not corrected.
Mosquito infection. Anopheles stephensi mosquitoes were fed on mice in-
fected with P. berghei ANKA RCon or mutant parasites. Days 10–22 after in-
fective blood meal, mosquito midguts, salivary glands, and hemolymph were 
harvested for determination of sporozoite numbers. For midgut and salivary 
gland sporozoites, organs from 20 mosquitoes were pooled and homoge-
nized, and released sporozoites were counted using a hemocytometer. 
Hemolymph from 20 mosquitoes was collected by perfusion of the thorax and 
abdomen with DME, and sporozoites were counted on a hemocytometer.
Indeed, CSP-based subunit vaccines have been a focus of the 
malaria vaccine effort, culminating in ongoing phase III trials 
with RTS,S, a vaccine candidate composed of the CSP repeat 
region and C terminus (Ballou, 2009). RTS,S is designed to 
include important T cell epitopes from the C terminus that 
induce cellular responses targeting the infected hepatocyte 
and B cell epitopes in the repeat region that lead to the pro-
duction of antibodies targeting the sporozoite. The inclusion 
of the CSP repeat region in RTS,S reflects previous findings 
that high antibody titers to this immunodominant region can 
inhibit sporozoite infectivity in rodent models (Sinnis and 
Nardin, 2002). Nonetheless, it has been difficult to translate 
these findings to humans in part because of the difficulty in 
generating sufficiently high antibody titers (Sinnis and Nardin, 
2002). Our current findings are relevant to the generation of 
protective antibody responses using CSP-based vaccines. 
First, we show that similar to HIV (Zolla-Pazner, 2004), malaria 
sporozoites expose a critical cell-adhesive motif at the moment 
of cell invasion and that this “just-in-time” exposure protects 
sporozoites from the action of antibodies that target the TSR. 
Therefore, inclusion of the CSP C terminus in a vaccine should 
focus on the important T cell epitopes found in this portion of 
the protein and not on generating TSR-specific antibodies. 
Second, our work demonstrates that proteolytic processing of 
CSP is critical for sporozoite infectivity in the mammalian host 
and suggests that antibodies that specifically target this function 
could be the foundation for a more potent and effective vaccine. 
In addition, the conservation of the cleavage site among all spe-
cies of Plasmodium may make it possible to target all human- 
infecting species with one immunogen. In light of our findings, 
it is encouraging to note that the antibody response to the 
N terminus of CSP has recently been shown to be associated with 
protection (Bongfen et al., 2009). Overall, these data provide 
important structure–function information that should guide fur-
ther work in designing subunit malaria vaccines.
MATERIALS AND METHODS
Generation of mutant CSP genes. Mutant CSP genes were generated 
using a PCR-based approach (Fig. S1 A). In each case, two gene fragments 
flanking the region to be deleted and including engineered or endogenous 
restriction sites were amplified and cut to yield fragments that when ligated 
made a CSP mutant containing the desired deletion. For the RI CSP, 
the amino acids KLKQP were deleted using the following strategy: a 128-
bp 5 fragment from the CSP open reading frame was amplified by PCR 
using forward primer P1 (5-GTATCACGTGCTTAACTCTAAG-3; 
existing Pml1 site underlined) and P2 (5-GCAATATTATTACGCTC-
TATTTTTTCG-3; introduced SspI site underlined). For the Nfull 
mutant, the amino acids NKSIQAQRNLNELCYNEGNDNKLYHV-
LNSKNGKIYNRNTVNRLLADAPEGKKNEKKNEKIERNNKLKQP, 
which encompass the entire N terminus excluding the signal sequence, were 
deleted as follows: a 5 722-bp fragment was amplified using forward primer 
P5 (5-AAAAAAGGTACCAAATATTATATGC-3; existing KpnI site 
underlined) and reverse primer P6 (5-AGAGCAGCTCGCCATATCCT-
GGAAGTAGAG-3; introduced PvuII site underlined). For all mutants, a 
776-bp 3 CSP fragment was amplified using forward primer P3 (5-GAGC-
GTAATAATAAATTGAAACAAAGGCCTCCACCACCAAACCC-3; 
introduced StuI site underlined) and reverse primer P4 (5-GTTTATTTA-
ATTAAAGAATACTAATAC-3; existing PacI site underlined). Both PCR 
products were gel purified using the QIAquick gel extraction kit (QIAGEN) 
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sporozoites were preincubated with 10 µM E-64d for 15 min at 25°C to de-
termine the proportion of intracellular sporozoites that had productively 
invaded. For experiments testing the effect of -C serum on invasion, spo-
rozoites were added to the cells in the presence of a 1:10 dilution of the anti-
serum. For all invasion assays, sporozoites were incubated with cells for 1 h 
at 37°C, washed, fixed, and stained with a double staining assay that distin-
guishes intracellular from extracellular sporozoites (Rénia et al.,1988). 
To assess productive invasion by Nfull sporozoites, sporozoites were incu-
bated with cells for 6 h at 37°C, washed, fixed with methanol, and stained 
with UIS-4 antiserum (1:500 dilution), followed by anti–rabbit Ig–Alexa 
Fluor 594 and 1 µg/ml mAb 3D11, followed by anti–mouse Ig-FITC. 
To quantify EEF development, cells with sporozoites were grown for an ad-
ditional 2 d, after which they were fixed with methanol and stained with 
mAb 2E6, followed by anti–mouse Ig-FITC.
Quantification of liver stage burden. Swiss Webster and C57BL/6 mice 
were injected i.v. or i.d. with 104 sporozoites. 40 h later, livers were har-
vested, total RNA was isolated, and liver parasite burden was quantified by 
RT-qPCR as outlined previously (Bruña-Romero et al., 2001) using prim-
ers that recognize P. berghei–specific sequences within the 18S rRNA 
(Kumar et al., 2004). 10-fold dilutions of a plasmid construct containing 
the P. berghei 18S rRNA gene were used to create a standard curve. For 
experiments testing the effect of -C serum on hepatocyte invasion, mice 
were injected i.v. with 1.5 mg of Ig fraction and 5 min later injected i.v. 
with sporozoites.
Determination of prepatent period. Mice were injected i.v. or i.d. with 
the indicated number of sporozoites, and the onset of blood stage infection 
was determined by observation of Giemsa-stained blood smears, beginning 
on day 3 after inoculation.
Quantification of sporozoites in mosquito organs. Midguts, salivary 
glands, thoraces, and abdomens from 20 infected mosquitoes were dissected, 
added to 1 ml of Tri-Reagent containing 5 µl polyacryl carrier, and homog-
enized, and total RNA was isolated. The number of sporozoites in each 
sample was determined by RT-qPCR using primers that recognize P. berghei–
specific sequences within the 18S rRNA as outlined previously (Bruña-
Romero et al., 2001; Kumar et al., 2004). Sporozoite numbers were 
determined using a standard curve of 102 to 105 sporozoites that were pro-
cessed in the same way the samples were processed.
Quantification of parasite number in the skin. The number of parasites 
remaining in the inoculation site was determined as previously described 
(Yamauchi et al., 2007). In brief, Swiss Webster mice were anesthetized, and 
5,000 sporozoites were injected i.d. into the pinna of the ear. The injected 
ears were removed at the indicated time points, weighed, cut into small 
pieces, and digested overnight at 50°C with proteinase K. Total genomic 
DNA was extracted using the DNeasy tissue kit (QIAGEN), and parasite 
DNA was quantified using nested PCR followed by qPCR as previously 
outlined (Yamauchi et al., 2007). Parasite numbers were determined using a 
standard curve made from mouse ears spiked with 0, 200, 1,000, and 5,000 
sporozoites that were processed in the same way the experimental samples 
were processed.
Quantification of gene expression in skin parasites. Swiss Webster 
mice were anesthetized, and 5,000 sporozoites in 5 µl were injected i.d. into 
the pinna of the ear. RNA extraction and RT-qPCR were performed as 
previously outlined (Medica and Sinnis, 2005). At the indicated time points, 
the injected ears were removed, weighed, snap frozen in liquid nitrogen, and 
stored at 80°C until RNA was extracted. The weight of each excised ear 
did not exceed 20 mg. Ears were then homogenized in 1.6 ml of Tri-Re-
agent using a Brinkmann Polytron homogenizer for 1 min and extracted 
with 320 µl chloroform. The aqueous phase was removed and mixed with 
an equal volume of 70% ethanol, and RNA was isolated using an RNeasy 
Mini spin column (QIAGEN) according to the manufacturer’s instructions. 
Cells and antibodies. Hepa1-6 (CRL-1830; American Type Culture 
Collection) and MDFs (Coppi et al., 2007) were maintained in DME sup-
plemented with 10% FCS and 1 mM glutamine (DME/FCS). HBMVEC, a 
human endothelial cell line (CC-2811; Cambrex), was grown in EGM-2MV 
media (Cambrex) supplemented with 5% FCS. mAb 3D11 is directed against 
the repeat region of P. berghei CSP (Yoshida et al.,1980); mAb 2E6 is di-
rected against Plasmodium Hsp70 (Tsuji et al., 1994); and UIS-4 antisera, a 
gift from S. Kappe (Seattle Biomedical Research Institute, Seattle, WA), is 
specific for the hepatic stage PV (Tarun et al., 2007). Polyclonal antisera to 
the N- and C-terminal portions of P. berghei CSP were generated using pep-
tides that spanned the entire N and C termini of P. berghei CSP as previously 
outlined (Coppi et al., 2005). For experiments testing the effect of -C 
serum on hepatocyte invasion, the IgG fraction was isolated by protein A 
purification (Vivapure maxiprepA; Sartorius).
Immunoblot of sporozoite lysates. Sporozoites were lysed in reducing 
sample buffer, and 104 sporozoite equivalents/lane were loaded and sepa-
rated by SDS-PAGE and transferred to polyvinylidene fluoride membrane. 
The membrane was cut between the 52- and 76-kD markers, and the top 
half was incubated with a 1:100 dilution of rabbit polyclonal antisera to the 
repeat region of P. berghei TRAP followed by anti–rabbit Ig conjugated to 
horseradish peroxidase, and the bottom half was incubated with 1 µg/ml 
mAb 3D11 followed by anti–mouse Ig conjugated to horseradish peroxidase. 
Bound antibodies were visualized using enhanced chemiluminescence 
(GE Healthcare).
Metabolic labeling and immunoprecipitation. P. berghei sporozoites 
were metabolically labeled in DME without Cys/Met, 1% BSA, and 
400 µCi/ml l-[35S]Cys/Met for 1 h at 28°C and then kept on ice or chased 
at 28°C for the indicated times as outlined previously (Coppi et al., 2005). 
To investigate the kinetics of processing in the presence of hepatocytes, spo-
rozoites were labeled as above, chased at 28°C for 1 h, and then centrifuged 
(300 g) onto Hepa1-6 cells on glass coverslips and subjected to an additional 
chase for 5, 15, or 30 min at 37°C. In all cases, chased sporozoites were lysed, 
and labeled CSP was immunoprecipitated with mAb 3D11 conjugated 
to Sepharose, eluted from the beads, and analyzed by SDS-PAGE using 
10 × 10.5–cm gels (SE260 system; Hoefer) followed by autoradiography.
Immunofluorescence. Sporozoites from oocysts, hemolymph, and sali-
vary glands were fixed with 4% PFA, washed, blocked with PBS/BSA, and 
incubated with polyclonal -N or -C sera (1:100 dilution), followed by 
anti–rabbit Ig-FITC or 1 µg/ml mAb 3D11, followed by anti–mouse Ig. 
The total number of sporozoites was counted by phase-contrast microscopy, 
and the percentage of sporozoite staining was determined by fluorescence 
microscopy. For cell contact experiments, sporozoites were centrifuged onto 
coverslips with Hepa1-6 cells at 4°C and then incubated at 37°C for the 
indicated time points, fixed with 4% PFA, and stained with -N or -C 
sera for 75 min. For these experiments, we visualized all sporozoites with 
0.05 µg/ml mAb 3D11 added during the last 15 min of incubation. Binding 
of antibodies was revealed with anti–rabbit Alexa Fluor 594 and anti–mouse 
Ig-FITC. Specimens were photographed using a fluorescence microscope 
(E600; Nikon) and a digital camera (DXM1200; Nikon).
Electron microscopy. Midguts from infected mosquitoes were dissected at 
days 8, 10, and 12 after blood meal, fixed in 1% glutaraldehyde and 4% PFA in 
PBS for 5 d, and postfixed in 1% osmium tetroxide and 1.5% K3Fe(CN)6 in 
PBS for 2 h, followed by incubation in 0.5% uranyl acetate for 1 h. Midguts 
were dehydrated in increasing concentrations of ethanol and then incubated 
for 1 h in propylene oxide, followed by another incubation for 1 h in a 1:1 
mixture of propylene oxide and Epon (Electron Microscopy Sciences). Speci-
mens were subsequently embedded in Epon at 60°C for 2 d. Photographs 
were taken with a transmission electron microscope (EM10; Carl Zeiss, Inc.).
Invasion and development assays. 5 × 104 sporozoites were added to 
Hepa1-6, MDFs, or HBMVEC cells in Lab-Tek wells. In some experiments, 
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